28例重症颅内静脉窦血栓患者抗凝治疗与联合血管内治疗预后分析  

Prognosis analysis of anticoagulant therapy combined with endovascular therapy in 28 patients with severe Cerebral venous sinus thrombosis

作　　者：吴泽宇 岑键昌 凡艺月 常谦 李俊彦 钱晓敏 苏平 WU Zeyu;CHEN Jianchang;FAN Yiyue(Department of Pain,Nanchong Central Hospital,Nanchong 637000,China)

机构地区：[1]南充市中心医院疼痛科,四川南充637000 [2]昆明医科大学附属甘美医院神经外科,云南昆明650011 [3]成都中医药大学,四川成都610000

出　　处：《中风与神经疾病杂志》2021年第1期14-17,共4页Journal of Apoplexy and Nervous Diseases

基　　金：云南省颅脑损伤研究中心资助项目(2017NS086)。

摘　　要：目的分析重症颅内静脉窦血栓(Cerebral Venous Sinus Thrombosis,CVST)患者二种治疗方法的短期预后,探讨重症CVST患者的最佳治疗方法。方法回顾分析2013年1月至2019年1月昆明市第一人民医院神经外科28例确诊为CVST重症患者,分为单纯抗凝治疗组与抗凝联合血管内治疗组,分析比较二组的短期预后。结果抗凝联合血管内治疗组的短期预后良好率优于单纯内科抗凝组,差异具有统计学意义(P<0.05)。结论对于重症CVST抗凝治疗效果差患者,可尝试介入治疗,能有效改善患者短期预后。Objective To analyze the short-term prognosis of two treatment methods for severe Cerebral venous sinus thrombosis(Cerebral Venous Sinus Thrombosis,CVST)and to explore the best treatment for severe CVST patients.Methods From January 2013 to January 2019,28 patients with severe cvst were diagnosed by neurosurgery in the first people’s hospital of Kunming.They were divided into two groups:simple internal anticoagulant therapy,anticoagulation and combined endovascular treatment.Results Anticoagulant combined with intravascular treatment group has a better short-term prognosis than that of medical anticoagulant group alone,the difference is statistically significant(P<0.05).Conclusions For patients with severe CVST,interventional therapy can be tried to improve the short-term prognosis.

关 键 词：颅内静脉窦血栓形成 抗凝 血管内治疗 短期预后 

分 类 号：R743[医药卫生—神经病学与精神病学]